ArticleClinical transplantation2026
Initial Experience With Single-Port Robotic Donor Nephrectomy Using the da Vinci SP System: A Case Series Evaluating Safety, Feasibility, and Early Outcomes.
Article in Clinical transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMinimally invasive techniques for living donor nephrectomy have advanced considerably, with robotic-assisted approaches offering improved visualization, reduced morbidity, and enhanced cosmesis. Single-port robotic donor nephrectomy (SP-RDN), utilizing the da Vinci SP platform, further minimizes the surgical footprint while aiming to maintain safety and efficacy. This case series presents our initial experience with SP-RDN, focusing on perioperative outcomes and early postoperative renal function.
methodsWe retrospectively reviewed six consecutive SP-RDNs performed between December 2023 and April 2025. Demographic data, operative parameters, and renal function markers were analyzed. All procedures were performed via a periumbilical incision using the da Vinci SP system by two surgeons at our institution. Perioperative outcomes, including operative time, estimated blood loss (EBL), warm ischemia time (WIT), and hospital stay, were assessed. Renal function was monitored using serum creatinine and estimated glomerular filtration rate (eGFR) preoperatively, on postoperative day (POD) 0 and POD1, and at first follow-up.
resultsMean donor age was 42 years (range 24-69), with an average BMI of 22.8 kg/m
conclusionSP-RDN is a feasible and safe approach for living donor nephrectomy, with favorable early outcomes. Larger studies are needed to confirm its advantages over traditional techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.